Abstract: The relationship between vitamin D and breast cancer is still controversial. The present meta-analysis examines the effects of the 25(OH)D, 1,25(OH)2D and vitamin D intake on breast cancer risk. For this purpose, a PubMed, Scopus and Web of Science-databases search was conducted including all papers published with the keywords "breast cancer" and "vitamin D" with at least one reported relative risk (RR) or odds ratio (OR). In total sixty eight studies published between 1998 and 2018 were analyzed. Information about type of study, hormonal receptors and menopausal status was retrieved. Pooled OR or RR were estimated by weighting individual OR/RR by the inverse of their variance Our study showed a protective effect between 25 (OH) D and breast cancer in both cohort studies (RR?=?0.85, 95%CI:0.74-0.98) and case-control studies (OR?=?0.65, 95%CI: 0.56-0.76). However, analyzing by menopausal status, the protective vitamin D - breast cancer association persisted only in the premenopausal group (OR?=?0.67, 95%CI: 0.49-0.92) when restricting the analysis to nested case-control studies. No significant association was found for vitamin D intake or 1,25(OH)2D.
This systematic review suggests a protective relationship between circulating vitamin D (measured as 25(OH) D) and breast cancer development in premenopausal women.
Fuente: Sci Rep. 2018 Jun 13;8(1):9039
Editorial: Nature Publishing Group
Año de publicación: 2018
Nº de páginas: 13
Tipo de publicación: Artículo de Revista
Url de la publicación: https://dx.doi.org/10.1038/s41598-018-27297-1
Consultar en UCrea Leer publicación
INES GOMEZ ACEBO
CAMILO PALAZUELOS CALDERON
FRANCISCO JAVIER LLORCA DIAZ
TRINIDAD DIERSSEN SOTOS